CRISPR/Cas9 Cellular Engineering for the Creation of Coagulation Factor-Based Resuscitation Fluid to Combat Hemorrhage and Coagulopathy
|Effective start/end date||6/16/20 → 6/15/23|
- THE GENEVA FOUNDATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.